The study aimed to create a system for inducing polyploid giant cancer cells (PGCCs) and to explore their characteristics and clinical importance in laryngeal cancer.
Researchers used paclitaxel liposomes to induce PGCCs and assessed protein expression related to cancer progression and stem cell markers through western blot analysis.
Results indicated that the induction was successful, with significant changes in protein expression and a negative correlation between PGCC count and patient survival, suggesting PGCCs may contribute to a worse prognosis in laryngeal cancer patients.